https://assets.hillrom.com/is/image/hillrom/rv700_doc_office_4601-seo-card?$recentlyViewedProducts$
article-detail-page
knowledge
close
language Country
menu
keyboard_arrow_left
Solutions
close

keyboard_arrow_left
Products
close

Quick Links

keyboard_arrow_left
Services
close

Quick Links

keyboard_arrow_left
Knowledge
close

keyboard_arrow_left
Profile
close

search
language
keyboard_arrow_left
United States
English

THE SOLUTION IS IN SIGHT

The Complete Guide to Successful Teleretinal Programs [eBook]

""

Diabetic retinopathy is the leading cause of blindness among working-age adults. This is a serious issue as the number of people living with diabetes increases, so does the number of people with impaired vision. There are approximately 537 million people in the world living with diabetes1 and up to 80% of individuals with diabetes will develop some level of diabetic retinopathy.2 Between 40-45% of Americans diagnosed with diabetes have some stage of diabetic retinopathy, although only about half are aware of it.3 But the solution is in sight – diabetic retinopathy is up to 95% preventable with early detection and treatment.

Check out the interactive eBook, The Solution is in Sight: The Complete Guide to Successful Teleretinal Programs, to learn more about what teleretinal imaging can do for your patients and primary care practice.

What’s inside the eBook:

  • An overview of diabetic retinopathy and the current standard of care 
  • How to select the right retinal camera for your workflow 
  • The three keys to a successful teleretinal program 
  • CPT Code coverage for fundus imaging and teleretinal programs 
  • Helping to improve HEDIS measures and STAR ratings by closing care gaps4
cover of the eBook titled The Complete Guide to Successful Teleretinal Programs

Related Articles

keyboard_arrow_up
Diabetic Retinal Exam FAQs Key Facts About Diabetic Retinopathy for Your Patients and Staff [Infographic]

Rx Only: For safe and proper use of the products mentioned herein, please refer to the appropriate Operator’s Manual or Instructions for Use.

References

  1. IDF Diabetes Atlas, Tenth Edition; International Diabetes Federation, 2021. https://diabetesatlas.org/.  Accessed October 9, 2024.
  2. Diabetic Retinopathy Preferred Practice Pattern® from the American Academy of Ophthalmology, http://dx.doi.org/10.1016/j.ophtha.2019.09.025, ISSN 0161-642
  3. National Institute of Health - National Eye Institute. Diabetic Retinopathy - What you Need to Know. Revised 9/15.
  4. Mansberger SL, Gleitsmann K, Gardiner S, et al. Comparing the effectiveness of telemedicine and traditional surveillance in providing diabetic retinopathy screening examinations: A randomized controlled trial. Telemed J E Health. 2013 Dec; 19(12): 942-8.

Baxter, Hillrom, RetinaVue and Welch Allyn are trademarks of Baxter International Inc. or its subsidiaries.
Any other trademarks, product names or brand images appearing herein are the property of their respective owners.
US-FLC147-240134 (v1.0) 10/2024